Medical technologies proof of concept
Maximum duration: up to 2 years
Maximum costs: £100,000
Deadline: expression of interests 13 June 2016
Contact: Sarah Odoi at firstname.lastname@example.org
What does the translational medical technologies development fund provide?
Funding is intended to develop or evaluate innovative technologies that help support individuals suffering with musculoskeletal conditions; in particular projects that develop the following:
- medical devices
- implantable therapeutic delivery
Who can apply for funding?
Any academic, clinician and allied health care professional at a UK institution.
Collaborations with industry are strongly encouraged.
What can you apply for?
Maximum support that can be requested is £100,000.
Requested salary costs should be based on a recognised pay model or the host institution’s local salary scale, including London weighting if appropriate. We must be advised of the pay model used and, where a local pay model is to be applied, a copy of the appropriate scale must be sent with the application. Annual increments must be included which should be based on the host institution’s own salary scale, including London weighting if appropriate.
Those interested in learning more about the call are encouraged to read the Medical Technologies Proof of Concept Award call document.
Register at the annual Regener8-Medical Technologies IKC conference to listen to past recipients of the proof of concept awards and the opportunity to book a 1 to 1 session with a member of the team.
How to apply
Expression of Interest applications should be submitted by 5pm 13th June 2016 and sent to email@example.com.